Multiple myeloma trials in Italy

In Italy 74 Also abroad 703

74 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Where
Ancona, Catania, Meldola, Palermo, Pavia, Pisa, Rome
Age
18 years and over
People
520 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00
No phaseTaking people
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
Where
Bari, Catania, Pavia, Torino
Age
18 years to 99 years
People
760
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06383143
Phase 2Taking people
Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
Where
Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara, Pescara, Rome, Turin, Varese
Age
18 years and over
People
150 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT07107529 · EU 2024-520433-76-00
No phaseTaking people
A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma
Where
Bari, Milan, Parma
Age
18 years to 75 years
People
62
Run by
Ciceri Fabio
See details and how to joinNCT07069751
Phase 1Taking people
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Where
Brescia, Milan
Age
18 years and over
People
200 worldwide
Run by
Ichnos Sciences SA
See details and how to joinNCT05862012 · EU 2023-507071-21-01
Phase 1Taking people
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Where
Rozzano, Torette
Age
18 years and over
People
87 worldwide
Run by
Sanofi
See details and how to joinNCT06630806
Phase 3Taking people
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Where
Alexandria, Ancona, Bari, Bologna, Brescia, Catania, Cuneo, Florence, Genoa, Legnano, Meldola, Milan, Padova, Palermo, Pavia, Reggio Emilia, Rimini, Rome, San Giovanni Rotondo, Turin, Udine
Age
18 years and over
People
1,000 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome, Turin
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
No phaseTaking people
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Where
Pavia
Age
18 years to 99 years
People
100
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT07448779
No phaseTaking people
Feasibility of a Multi-omics Platform for Hematological Malignancies
Where
Parma
Age
2 years and over
People
1,040
Run by
Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07445438
No phaseTaking people
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Where
Bari, Catania, Padova, Treviso
Age
18 years and over
People
75 worldwide
Run by
Takeda
See details and how to joinNCT05879757
No phaseTaking people
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Where
Palermo, Perugia
Age
1 year and over
People
300
Run by
Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07403630
No phaseTaking people
European Myeloma Network (EMN) Sample Project
Where
Alessandria, Ancona, Bari, Bologna, Brescia, Civitanova Marche, Florence, Genova, Lecce, Naples, Novara, Pavia, Roma, San Giovanni Rotondo, Terni, Torino, Udine, Vicenza
Age
18 years and over
People
6,000 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT06237803
No phaseTaking people
Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
Where
Florence
Age
18 years and over
People
159
Run by
Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06933277
No phaseTaking people
Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers
Where
Reggio Emilia
Age
18 years and over
People
190
Run by
Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07014865
Phase 2Not yet taking people in Italy
Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma
Where
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Candiolo, Catania, Florence, Genoa, Padova, Pavia, Reggio Calabria, Reggio Emilia, Rome, Trieste, Turin, Udine, Vicenza
Age
18 years and over
People
52
Run by
Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06880601 · EU 2025-521827-61-00
No phaseTaking people
Whole Body MRI in Oncology
Where
Bologna, Meldola, Milan
Age
18 years and over
People
1,000
Run by
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06895291
No phaseTaking people
Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment
Where
Roma
Age
18 years and over
People
736
Run by
Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06028087
No phaseTaking people
Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
Where
Bologna
Age
18 years and over
People
30
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06874530
No phaseTaking people
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
Where
Bologna, Cagliari, Meldola, Naples
Age
18 years and over
People
200
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06767254
No phaseTaking people
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Where
Reggio Emilia
Age
18 years and over
People
45
Run by
University of Modena and Reggio Emilia
See details and how to joinNCT06236373
No phaseTaking people
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
Where
Bologna
Age
18 years and over
People
83
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06659276
No phaseTaking people
DAratumumab and REvlimid REfractory MM
Where
Pavia
Age
18 years and over
People
100
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06541860
No phaseTaking people
Bergamo Lymphoid Cancer Registry
Where
Bergamo
Age
18 years and over
People
6,000
Run by
A.O. Ospedale Papa Giovanni XXIII
See details and how to joinNCT03131531